A selection of major announcements

1. New Oriental-S: Q2 net profit of FY2024 was US$30.66 million, a year-on-year increase of 4007.4%

$NEW ORIENTAL-S (09901.HK)$The results for the second quarter of fiscal year 2024 were announced, achieving net revenue of US$869.6 million, up 36.3% year on year; net profit of US$30.66 million, up 4007.4% year on year; adjusted net profit of US$50,158,000, up 182.6% year on year; adjusted earnings per ADS of US$0.29 million, US$0.1 million in the same period last year; net revenue for the third quarter was estimated to be US$1.07 billion to US$1.09 billion, up 42% to 45% year on year.

2. Oriental Selection: Net profit for the fiscal year 2024 was 249 million yuan, down 57.4% year on year

$EAST BUY (01797.HK)$According to the Hong Kong Stock Exchange announcement, total revenue for the mid-fiscal year 2024 (six months ending November 2023) was 2.795 billion yuan, up 34.4% year on year; net profit was 249 million yuan, down 57.4% year on year. Oriental Selection's GMV for the six months ended November 30, 2023 was 5.7 billion yuan, compared to 4.8 billion yuan in the same period last year; the number of followers on Douyin was 45.8 million, compared to 35.2 million in the same period last year; the number of paid orders on Douyin was 59.6 million, compared to 70.2 million for the same period last year.

3. China Railway Construction: The total amount of new contracts signed in 2023 was 3.29 trillion yuan, an increase of 1.51% over the previous year

$CHINA RAIL CONS (01186.HK)$According to the announcement, the amount of new contracts signed last year was about RMB 3.29 trillion (same below), an increase of 1.51% year-on-year; among them, the amount of new contracts signed domestically increased by 3.47% year-on-year to 3.04 trillion yuan, while the amount of new contracts signed overseas decreased by 17.38% to 252,846 billion yuan. In the fourth quarter alone, the company signed a new contract amount of 1.51 trillion yuan.

4. Cathay Pacific: Passenger capacity exceeded 20 million in 2023

$CATHAY PAC AIR (00293.HK)$According to the announcement, the number of passengers carried over 20 million in 2023, the number of passengers carried increased by 541.5% year on year, the number of available seat kilometers increased by 326.8% year on year, while the number of passenger kilometers earned rose 396.8% year on year.

Earnings Report

$NEW ORIENTAL-S (09901.HK)$Q2 net revenue for FY2024 was US$870 million, up 36.3% year over year

$EAST BUY (01797.HK)$Net profit for the 2024 fiscal year was 249 million yuan, down 57.4% year on year

$ZOOMLION (01157.HK)$: Expected annual net profit of 3.38 billion yuan - 3.62 billion yuan, a year-on-year increase of 46.57%-56.98%

$JOINN (06127.HK)$: Expected net profit of 311 million yuan to 418 million yuan in 2023, a year-on-year decrease of about 61.1% to 71.1%

Operational data

$CHINA RAIL CONS (01186.HK)$The cumulative amount of new contracts signed in 2023 was 3.29 trillion yuan, up 1.51% year-on-year

$SHENZHEN INVEST (00604.HK)$Total contract sales in 2023 were about 26.586 billion yuan, up 38.4% year on year

$CATHAY PAC AIR (00293.HK)$Passengers carried more than 20 million in the full year of 2023

Pharmaceutical Innovation

$BOAN BIOTECH (06955.HK)$: Innovative products BA1105 and BA1301 have been re-qualified as orphan drugs by the FDA to treat gastric cancer

$ASCLETIS-B (01672.HK)$Announcing the completion of the phase III clinical trial of ASC40 (denifastat) for acne

$GRANDPHARMA (00512.HK)$: The application for clinical trial of the Group's global innovative therapeutic tumor vaccine ARC01 in China was approved by the Drug Administration

$ZHAOKE OPHTH-B (06622.HK)$: Clinical trial applications for BRIMOCHOL PF and CARBACHOL PF new drugs for presbyopia were approved by the National Drug Administration

Repurchase cancellation

$HSBC HOLDINGS (00005.HK)$On January 23, it cost HK$148 million to repurchase 2.498 million shares

$Baozun (BZUN.US)$-SW (09991.HK) announces $20 million share repurchase plan

$XIAOMI-W (01810.HK)$On January 24, it cost HK$94.73 million to buy back 7 million shares

$BEKE-W (02423.HK)$On January 23, it cost 6.95 million US dollars to buy back 1.494 million shares

$CHINASOFT INT'L (00354.HK)$On January 24, it cost HK$25.285,400 to buy back 5 million shares

$AIA (01299.HK)$On January 24, it cost HK$2007 million to buy back 325,800 shares

$SWIRE PACIFIC A (00019.HK)$On January 24, 269,000 shares were repurchased at HK$16.585,800

$COSCO SHIP HOLD (01919.HK)$1.78 million shares were repurchased at HK$14.323,500 on January 24

$WANT WANT CHINA (00151.HK)$On January 24, it spent HK$8.057,900 to repurchase 1,855,000 shares

Editor/Somer